Efficacy of New-Onset Type 1 Diabetes (T1D) Intervention Trials: Variation in 1-Year Outcomes | American Diabetes Association

Efficacy of New-Onset Type 1 Diabetes (T1D) Intervention Trials: Variation in 1-Year Outcomes

Speaker: Laura M Jacobsen
Session: New Insights into Immunomodulatory Therapies and Biomarkers of Autoimmune Disorder (With State-of-the-Art Lecture)
Congress: 79th Scientific Sessions